Trade RXRX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Recursion Pharmaceuticals, Inc. Class A (RXRX) is trading at US$3.83, up 8.19% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$1.88B. Over the past 52 weeks, RXRX has traded between US$2.77 and US$7.18. On Syfe you can trade RXRX with $0 commission and add it to your watchlist.
| Previous close | US$3.54 |
|---|---|
| Market cap | US$1.88B |
| 52-week range | US$2.77 – US$7.18 |
| Volume | 43.85M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Recursion Pharmaceuticals, Inc. Class A
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.
Year: 2021
Contineum, Disc Medicine, Recursion Advance Pipelines Ahead of Catalysts, Morgan Stanley Says
Aug 17, 3:01 PM · MT Newswires
Morgan Stanley Adjusts PT on Recursion Pharmaceuticals to $5.30 From $5.50, Keeps Equalweight Rating
Aug 17, 9:54 AM · MT Newswires
Recursion Pharmaceuticals Shares Fall After Q2 Miss
Aug 5, 1:53 PM · MT Newswires
--Earnings Flash (RXRX) Recursion Pharmaceuticals Posts Q2 Loss $0.25 a Share, vs. FactSet Est of $0.28 Loss
Aug 5, 10:45 AM · MT Newswires
-- Earnings Flash (RXRX) Recursion Pharmaceuticals Inc Reports Q2 Revenue $7.7M
Aug 5, 10:36 AM · MT Newswires
Recursion Pharmaceuticals, Inc. Class A (RXRX) stock is trading at US$3.83, +8.19% from the previous close of US$3.54.
The market cap for Recursion Pharmaceuticals, Inc. Class A (RXRX) stock is approximately US$1.88B.
The 52-week high for Recursion Pharmaceuticals, Inc. Class A (RXRX) stock is US$7.18.
The 52-week low for Recursion Pharmaceuticals, Inc. Class A (RXRX) stock is US$2.77.
Recursion Pharmaceuticals, Inc. Class A (RXRX) does not currently pay a dividend.
Stay on top of RXRX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
